ConductScience.org, home

Paper3552006

Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).

Jones DK and 2 others. Br Heart J, 1987. Cited by 159 papers, by iCite.

Cite this record

ConductScience Library. Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin). Papers, record 3552006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3552006

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).
PubMed
Journal
Br Heart J
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
159
iCite
Relative citation ratio, by iCite
6.46
iCite
Revised in PubMed
2019-05-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jones DKD K
2Higenbottam TWT W
3Wallwork JJ

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EpoprostenolMajor topic
Hypertension, PulmonaryMajor topic
Adolescent
Adult
Drug Administration Schedule
Female
Hemodynamics
Humans
Infusions, Intravenous
Male
Oxygen Consumption
Physical Exertion

Source PubMed

Download CSV of topics

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14682413Intrapulmonary veno-occlusive disease.Am J Cardiol1973https://conductscience.org/library/papers/4682413PubMed
214051185LOSS OF REACTIVITY OF THE PULMONARY VASCULAR BED IN PRIMARY PULMONARY HYPERTENSION.Am Heart J1963https://conductscience.org/library/papers/14051185PubMed
3441578The measurement of metabolic gas exchange and minute volume by mass spectrometry alone.Respir Physiol1979https://conductscience.org/library/papers/441578PubMed
47350435Oral hydralazine therapy for primary pulmonary hypertension.N Engl J Med1980https://conductscience.org/library/papers/7350435PubMed
57350437Diazoxide in primary pulmonary hypertension.N Engl J Med1980https://conductscience.org/library/papers/7350437PubMed
66154242Vasodilator therapy for pulmonary hypertension.N Engl J Med1980https://conductscience.org/library/papers/6154242PubMed
77295436Hazards of diazoxide in pulmonary hypertension.Br Heart J1981https://conductscience.org/library/papers/7295436PubMed
87060242Unexplained pulmonary hypertension.Circulation1982https://conductscience.org/library/papers/7060242PubMed
97070457Deleterious effects of hydralazine in patients with pulmonary hypertension.N Engl J Med1982https://conductscience.org/library/papers/7070457PubMed
106804111Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.Circulation1982https://conductscience.org/library/papers/6804111PubMed
117046988Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.Circulation1982https://conductscience.org/library/papers/7046988PubMed
127049203Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.Br Heart J1982https://conductscience.org/library/papers/7049203PubMed
137049212Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7049212PubMed
146849224Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.Am Heart J1983https://conductscience.org/library/papers/6849224PubMed
156625374Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation.Ann Intern Med1983https://conductscience.org/library/papers/6625374PubMed
166652000Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.Br Heart J1983https://conductscience.org/library/papers/6652000PubMed
176143976Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin).Lancet1984https://conductscience.org/library/papers/6143976PubMed
186148159Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation1984https://conductscience.org/library/papers/6148159PubMed
196148512Rebound platelet activation during continuous epoprostenol infusion.Lancet1984https://conductscience.org/library/papers/6148512PubMed
206482934Right-sided infective endocarditis as a consequence of flow-directed pulmonary-artery catheterization. A clinicopathological study of 55 autopsied patients.N Engl J Med1984https://conductscience.org/library/papers/6482934PubMed

See all 23 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.

PMIDTitleJournalYearIn PapersSource
40013009How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension.Pulm Circ2025https://conductscience.org/library/papers/40013009PubMed
39906119Pulmonary Hypertension: A Personal Journey.Pulm Circ2025https://conductscience.org/library/papers/39906119PubMed
35859133Assessment of disease outcome measures in systemic sclerosis.Nat Rev Rheumatol2022https://conductscience.org/library/papers/35859133PubMed
35795488Epoprostenol-associated ascites in pulmonary arterial hypertension.Pulm Circ2022https://conductscience.org/library/papers/35795488PubMed
34776414A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities.Blood Res2021https://conductscience.org/library/papers/34776414PubMed
28126964Prostacyclin-analog therapy in sickle cell pulmonary hypertension.Haematologica2017https://conductscience.org/library/papers/28126964PubMed
25848300Prostanoid therapies in the management of pulmonary arterial hypertension.Ther Clin Risk Manag2015https://conductscience.org/library/papers/25848300PubMed
24937180Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.Chest2014https://conductscience.org/library/papers/24937180PubMed
24140503Elevated prostacyclin biosynthesis in mice impacts memory and anxiety-like behavior.Behav Brain Res2014https://conductscience.org/library/papers/24140503PubMed
21941650Diagnosis and management of pulmonary arterial hypertension.Pulm Med2011https://conductscience.org/library/papers/21941650PubMed
15846646Prostacyclin for pulmonary hypertension in adults.Cochrane Database Syst Rev2005https://conductscience.org/library/papers/15846646PubMed
12800450[Consensus recommendations of the Pulmonary Arterial Hypertension Study Group of the Austrian Society of Lung Diseases and Tuberculosis].Wien Klin Wochenschr2003https://conductscience.org/library/papers/12800450PubMed
11293650Drug treatment of scleroderma.Drugs2001https://conductscience.org/library/papers/11293650PubMed
10451689Pulmonary hypertension: its assessment and treatment.Thorax1999https://conductscience.org/library/papers/10451689PubMed
9813561Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension.Heart1998https://conductscience.org/library/papers/9813561PubMed
9711442The future potential of eicosanoids and their inhibitors in paediatric practice.Drugs1998https://conductscience.org/library/papers/9711442PubMed
9538312Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.Heart1998https://conductscience.org/library/papers/9538312PubMed
9155601Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin.Heart1997https://conductscience.org/library/papers/9155601PubMed
8708174The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism.Intensive Care Med1996https://conductscience.org/library/papers/8708174PubMed
8217447Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension.Br Heart J1993https://conductscience.org/library/papers/8217447PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3552006

GET https://conductscience.org/api/papers/v1/3552006/references?page=2